Cargando…
Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential
Migraine is an important socioeconomic burden and is ranked the sixth cause of years of life lost because of disability in the general population and the third cause of years of life lost in people younger than 50 years. The cornerstone of pharmacological treatment is represented by the acute therap...
Autores principales: | Negro, Andrea, Koverech, Angela, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848843/ https://www.ncbi.nlm.nih.gov/pubmed/29563831 http://dx.doi.org/10.2147/JPR.S132833 |
Ejemplares similares
-
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021) -
Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011) -
Migraine and cluster headache show impaired neurosteroids patterns
por: Koverech, Angela, et al.
Publicado: (2019) -
Serotonin Receptor Agonists in the Treatment of Migraine: A Meta-Analysis Considering Possible Connection with Paresthesia
por: Katalinic, Darko, et al.
Publicado: (2022) -
Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach
por: Koverech, Angela, et al.
Publicado: (2018)